|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Houston Center for Quality of Care and Utilization Studies (Drs. Kunik, Veazey, Souchek, Richardson, and Wray), Health Services Research and Development Service, Michael E. DeBakey Veterans Affairs Medical Center, Houston; and Department of Psychiatry (Drs. Roundy and Stanley), Baylor College of Medicine, Houston, TX.
Correspondence to: Mark E. Kunik, MD, MPH, Houston Center for Quality of Care and Utilization Studies, MEDVAMC (152), 2002 Holcombe, Houston, TX 77030; e-mail: mkunik{at}bcm.tmc.edu
Study objectives: The objectives of this study were to assess the prevalence, screening, and recognition of depression and anxiety in persons with chronic breathing disorders, including COPD.
Design: Cross-sectional study.
Setting: The Michael E. DeBakey Veterans Affairs Medical Center (MEDVAMC).
Participants: A large sample of 1,334 persons with chronic breathing disorder diagnoses who received care at the MEDVAMC.
Measurements: The prevalence of anxiety and depression was measured in a large sample of persons with a chronic breathing disorder diagnosis who received care at the MEDVAMC, using the Primary Care Evaluation of Mental Disorders (PRIME-MD) screening questions. The positive predictive value of the PRIME-MD questions was then determined. The prevalence of anxiety and depressive diagnoses in patients determined to have COPD was then measured, using the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (SCID).
Results: Of patients screened with the PRIME-MD, 80% screened positive for depression, anxiety, or both. The predictive value of a positive phone screen for either depression or anxiety was estimated to be 80%. In the subsample of patients who had COPD and received a diagnosis using the SCID, 65% received an anxiety and/or depressive disorder diagnosis. Of those patients, only 31% were receiving treatment for depression and/or anxiety.
Conclusions: It is troubling that a mere 31% of COPD patients with depression or anxiety are being treated, particularly given their high prevalence in this population. Practical screening instruments may help increase the recognition of anxiety and depression in medical patients, as suggested by the excellent positive predictive value of the PRIME-MD in our study.
Key Words: anxiety anxiety disorders depression depressive disorder lung diseases, obstructive prevalence pulmonary disease, chronic obstructive
This article has been cited by other articles:
![]() |
V. S. Fan, S. D. Ramsey, N. D. Giardino, B. J. Make, C. F. Emery, P. T. Diaz, J. O. Benditt, Z. Mosenifar, R. McKenna Jr, J. L. Curtis, et al. Sex, Depression, and Risk of Hospitalization and Mortality in Chronic Obstructive Pulmonary Disease Arch Intern Med, November 26, 2007; 167(21): 2345 - 2353. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. von Leupoldt, K. Taube, S. Schubert-Heukeshoven, H. Magnussen, and B. Dahme Distractive Auditory Stimuli Reduce the Unpleasantness of Dyspnea During Exercise in Patients With COPD Chest, November 1, 2007; 132(5): 1506 - 1512. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Laurin, K. L. Lavoie, S. L. Bacon, G. Dupuis, G. Lacoste, A. Cartier, and M. Labrecque Sex Differences in the Prevalence of Psychiatric Disorders and Psychological Distress in Patients With COPD Chest, July 1, 2007; 132(1): 148 - 155. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Adams, P. K. Smith, P. F. Allan, A. Anzueto, J. A. Pugh, and J. E. Cornell Systematic Review of the Chronic Care Model in Chronic Obstructive Pulmonary Disease Prevention and Management Arch Intern Med, March 26, 2007; 167(6): 551 - 561. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. von Leupoldt and B. Dahme Differentiation Between the Sensory and Affective Dimension of Dyspnea During Resistive Load Breathing in Normal Subjects Chest, November 1, 2005; 128(5): 3345 - 3349. [Abstract] [Full Text] [PDF] |
||||
![]() |
Minerva BMJ, July 9, 2005; 331(7508): E369 - E369. [Full Text] [PDF] |
||||
![]() |
Minerva BMJ, April 23, 2005; 330(7497): 974 - 974. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |